Search
KORU Medical Systems Inc
KRMDAdd to Watchlist
4.490USD
+0.090+2.05%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
207.14MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+2.05%
5 Days
+0.67%
1 Month
+8.45%
6 Months
-19.96%
Year to Date
-22.72%
1 Year
+24.03%
Key Figures
4.390Open
4.540High
116.48KVolume
LossP/E TTM
134.52P/E Dynamic
--Dividend TTM
0.25%Turnover Ratio
4.400Prev. Close
4.390Low
433.88KTurnover
LossP/E Static
12.24P/B
0.00%Div Yield TTM
-8.17%ROA
6.60852wk High
0.71Volume Ratio
-6.07MNet Profit
46.13MShares
-0.0492EPS TTM
0.43Beta
-13.70%ROE
2.68052wk Low
3.41%Amplitude
59.79%Gross Margin
207.14MMarket Cap
2.06Reward/Risk
3.05%Risk Rate
TradingKey Stock Score of KORU Medical Systems Inc
Currency: USD Updated: 2026-07-02Key Insights
KORU Medical Systems Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 74 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.80.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
KORU Medical Systems Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
KORU Medical Systems Inc Highlights
StrengthsRisks
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 44.22% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.13M.
Undervalued
The company’s latest PE is -91.33, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 28.85M shares, decreasing 0.45% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 190.81K shares of this stock.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
6.800
Target Price
+54.55%
Upside Space
KORU Medical Systems Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
KORU Medical Systems Inc Info
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Ticker SymbolKRMD
CompanyKORU Medical Systems Inc
CEOTharby (Linda M)
Websitehttps://www.korumedical.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of KORU Medical Systems Inc (KRMD)?
The current price of KORU Medical Systems Inc (KRMD) is 4.49.
What is the symbol of KORU Medical Systems Inc?
The ticker symbol of KORU Medical Systems Inc is KRMD.
What is the 52-week high of KORU Medical Systems Inc?
The 52-week high of KORU Medical Systems Inc is 6.61.
What is the 52-week low of KORU Medical Systems Inc?
The 52-week low of KORU Medical Systems Inc is 2.68.
What is the market capitalization of KORU Medical Systems Inc?
The market capitalization of KORU Medical Systems Inc is 207.14M.
Is KORU Medical Systems Inc (KRMD) currently rated as Buy, Hold, or Sell?
According to analysts, KORU Medical Systems Inc (KRMD) has an overall rating of Buy, with a price target of 6.80.
What is the Earnings Per Share (EPS TTM) of KORU Medical Systems Inc (KRMD)?
The Earnings Per Share (EPS TTM) of KORU Medical Systems Inc (KRMD) is -0.06.